MADRIGAL PHARMACEUTICALS, INC. (MDGL) Operating cash flow 2017–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$189.6MFY2025 · since FY2017: -$22.3M → -$189.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$189.6M | +58.4% |
| FY2024 | -$455.6M | -40.5% |
| FY2023 | -$324.2M | -44.2% |
| FY2022 | -$224.9M | -22.3% |
| FY2021 | -$183.9M | -16.7% |
| FY2020 | -$157.6M | -278.5% |
| FY2019 | -$41.6M | -63.2% |
| FY2018 | -$25.5M | -14.3% |
| FY2017 | -$22.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MDGL financial trends
MDGL RevenueMDGL Net incomeMDGL Net marginMDGL Gross profitMDGL Gross marginMDGL Operating incomeMDGL Operating marginMDGL Free cash flowMDGL Capital expendituresMDGL Return on equityMDGL Stock buybacksMDGL Dividends paidMDGL Total assetsMDGL Total liabilitiesMDGL Shareholders’ equityMDGL overview →